As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma
Crossref DOI link: https://doi.org/10.1245/s10434-015-5031-0
Published Online: 2015-12-16
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Desaki, Ryosuke
Sawada, Genta
Okumura, Hiroshi
Ikeda, Ryuji
Tanabe, Kan
Komatsu, Hisateru
Mimori, Koshi
Mori, Masaki
Kita, Yoshiaki
Uchikado, Yasuto
Arigami, Takaaki
Uenosono, Yoshikazu
Owaki, Tetsuhiro
Ishigami, Sumiya
Natsugoe, Shoji
Text and Data Mining valid from 2015-12-16